# Innovative Multilayered Electrospun Fiber Systems for Dual-Action HIV Prophylaxis and Nonhormonal Contraception

**Authors:** Deborah A. Ogundemuren, Peace-Ofonabasi O. Bassey, Karamot O. Oyediran, Ohakwe G. Nmesoma, Dimitrios Tsamos, Alkiviadis Tsamis, Alexander E. Tsouknidas, Andrew N. Amenaghawon, Chukwuemeka P. Azubuike, Margaret O. Ilomuanya

PMC · DOI: 10.1155/adpp/4749211 · 2025-06-29

## TL;DR

This study develops a multilayered fiber system that can deliver HIV prevention and contraceptive drugs in a single, on-demand dosage.

## Contribution

A novel multilayered electrospun fiber system for dual-action HIV prophylaxis and nonhormonal contraception is introduced.

## Key findings

- The system achieved 52.13% encapsulation efficiency for tenofovir and 63.86% for nifedipine.
- The top layer showed pH-responsive release, while the backing layer exhibited near-zero-order release.
- The fibers demonstrated Fickian diffusion in simulated vaginal fluid environments.

## Abstract

Background: Electrospun fiber drug delivery systems, integrated into multipurpose prevention technologies, offer a promising solution for women facing health risks from HIV/STIs and unmet contraceptive needs by providing on-demand protection in a single dosage form. This study investigates the potential of a multilayer electrospun fiber construct for pH-responsive and sustained release of the HIV microbicide tenofovir (TFV) and the CatSper channel blocker nifedipine (NFP) respectively.

Method: Electrospun fibers were fabricated in a stacked architecture by blend electrospinning using polycaprolactone (PCL) as the backing layer for delivering NFP and cellulose acetate phthalate (CAP) as the top layer for delivering TFV. An analysis of surface morphology, mechanical and chemical properties, mucoadhesion, drug release profiles, encapsulation efficiency, and safety assessments was performed.

Results: An encapsulation efficiency of 52.13% was achieved for TFV, with a drug loading of 7.00%, while for NFP, the encapsulation efficiency was 63.86%, with a drug loading of 0.56%. The top layer exhibited a pH-responsive release profile and Fickian diffusion in both SVF and SVF/SF environments, while the backing layer showed Fickian diffusion in SVF and a release profile closer to zero-order in SVF/SF.

Conclusion: This study highlights the potential of multilayered CAP/PCL electrospun fibers for intravaginal delivery of TFV and NFP, aimed at the pre-exposure prophylaxis of HIV-1 and prevention of unplanned pregnancy.

## Linked entities

- **Chemicals:** tenofovir (PubChem CID 464205), nifedipine (PubChem CID 4485), cellulose acetate phthalate (PubChem CID 53315792)

## Full-text entities

- **Diseases:** HIV/STIs (MESH:D012749)
- **Chemicals:** NFP (MESH:D009543), PCL (MESH:C016240), TFV (MESH:D000068698), CAP (MESH:C011708)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Homo sapiens (human, species) [taxon 9606]

## Figures

12 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12229729/full.md

---
Source: https://tomesphere.com/paper/PMC12229729